Related Experiment Video
Updated: May 31, 2026
Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
Published on: February 8, 2013
Contextual interpretation of luminal phenotype in low-grade breast epithelial proliferations
Emad A Rakha1,2
1School of Medicine, University of Nottingham - University Park Campus, Nottingham, UK emadrakha@yahoo.com.
Insights
Diagnosing breast epithelial proliferations can be challenging. This review offers a framework to differentiate non-neoplastic changes from neoplastic lesions, improving diagnostic accuracy and patient management.
Area of Science:
- Pathology
- Oncology
- Breast Imaging
Background:
- Distinguishing benign hyperplasia from neoplastic lesions in breast tissue relies on morphology and immunophenotyping.
- Challenges persist in differentiating non-clonal luminal epithelial proliferations from neoplastic precursors.
- Certain conditions like gynecomastia can present worrisome features despite a non-neoplastic context.
Purpose of the Study:
- To review diagnostic pitfalls in evaluating low-grade intraductal epithelial proliferations.
- To propose an integrated diagnostic framework for borderline breast lesions.
- To enhance diagnostic reproducibility and guide risk-adapted patient management.
Main Methods:
- Narrative review of diagnostic criteria for intraductal epithelial proliferations.
- Analysis of morphological, immunophenotypic, and clinical context in challenging cases.
- Emphasis on architectural features and clonal demarcation.
Main Results:
- Hormonally driven or stromal-induced differentiation can mimic neoplasia.
- Lesions may lack sharp demarcation typical of conventional neoplasia.
- Context-dependent interpretation is crucial for accurate diagnosis.
Conclusions:
- An integrated framework considering architecture, clonality, and clinical setting improves diagnostic accuracy.
- Refining diagnostic thresholds in context reduces overdiagnosis of breast lesions.
- This approach supports appropriate, risk-adapted patient management for borderline cases.
Abstract:
Diagnosing low-grade intraductal epithelial proliferations and distinguishing hyperplasia from neoplasia has traditionally relied on well-established morphological and immunophenotypic criteria. However, in routine practice, differentiating luminal epithelial proliferations that are not necessarily clonal from bona fide neoplastic precursor lesions remains challenging. In specific clinical scenarios, such as gynaecomastia, adolescent breast tissue and fibroepithelial lesions, epithelial proliferations may appear morphologically and immunophenotypically worrisome for neoplasia, yet the clinical context supports a non-neoplastic process. Rather than representing conventional clonal neoplasia, these changes may reflect hormonally driven or stromal-induced luminal differentiation and often lack the sharp demarcation typical of conventional neoplasia. This narrative review delineates these context-dependent diagnostic pitfalls and proposes an integrated framework that emphasises architectural features, clonal demarcation and the clinical setting. By positioning these borderline lesions within a biological continuum and refining diagnostic thresholds in context, this approach aims to improve diagnostic reproducibility, mitigate the risk of overdiagnosis and support appropriate, risk-adapted patient management.
